This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
20 Oct 2010

Celldex Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference

Thomas Davis, M.D and Chief Medical Officer of Celldex Therapeutics, Inc., will present in the Biotech Industry Conference on Friday, October 22nd, at 2:00 p.m. EDT in New York City.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Thomas Davis, M.D., Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc., will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, October 22nd, at 2:00 p.m. EDT in New York City.

A live webcast of the presentation will be available on the “Presentations” page of the “Investors” section of Celldex's website at http://www.celldextherapeutics.com and will be archived for 30 days following the event.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-target

Related News